Skip to main content
. 2024 May 23;9:89. doi: 10.1038/s41541-024-00876-2

Table 2.

Baseline characteristics of the full analysis set population

Ad26/MVA Ad26/Ad26 + gp140 Placebo All subjects
Analysis set: full analysis set 10 9 6 25
Age, years
N 10 9 6 25
Mean (SD) 42.1 (10.25) 37.9 (9.71) 44.8 (11.39) 41.2 (10.28)
Median (min; max) 44.5 (28;58) 39.0 (29;59) 47.5 (30;56) 41.0 (28;59)
Sex
N 10 9 6 25
Female 0 1 (11.1%) 2 (33.3%) 3 (12.0%)
Male 10 (100.0%) 8 (88.9%) 4 (66.7%) 22 (88.0%)
Race
N 9 7 6 22
Asian 1 (11.1%) 0 0 1 (4.5%)
Black or African American 0 0 1 (16.7%) 1 (4.5%)
Native Hawaiian or Other Pacific Islander 0 1 (14.3%) 0 1 (4.5%)
White 8 (88.9%) 6 (85.7%) 5 (83.3%) 19 (86.4%)
Ethnicity
N 9 9 6 24
Hispanic or Latino 4 (44.4%) 3 (33.3%) 2 (33.3%) 9 (37.5%)
Not Hispanic or Latino 5 (55.6%) 6 (66.7%) 4 (66.7%) 15 (62.5%)
Weight, kg
N 10 9 6 25
Mean (SD) 78.4 (8.06) 82.0 (17.76) 100.6 (19.00) 85.0 (16.95)
Median (min; max) 75.9 (68.3;93.3) 80.6 (62.2;121.2) 99.9 (74.8;128.4) 82.1 (62.2;128.4)
Height, cm
N 10 9 6 25
Mean (SD) 175.7 (4.83) 175.6 (6.96) 169.4 (9.85) 174.1 (7.24)
Median (min; max) 175.4 (169.0;185.8) 178.3 (165.4;184.1) 172.0 (152.0;179.7) 175.2 (152.0;185.8)
HIV RNA, copies/mL
N 10 9 6 25
Mean (SD) 21.4 (8.88) 21.2 (8.03) 15.7 (8.16) 20.0 (8.43)
Median (min; max) 19.0 (11;31) 19.0 (11;31) 11.0 (11;31) 19.0 (11;31)
CD4 Cell Count, /uL
N 10 9 6 25
Mean (SD) 695.1 (345.56) 672.7 (131.54) 775.3 (152.18) 706.3 (238.83)
Median (min; max) 566.5 (385;1377) 646.0 (521;895) 773.0 (521;950) 654.0 (385;1377)
Duration on current ART
N 10 9 6 25
Mean (SD) 1.573 (0.9509) 4.593 (6.1450) 1.244 (0.6480) 2.581 (3.9245)
Median (min; max) 1.235 (0.71; 3.25) 2.519 (0.82; 20.36) 0.976 (0.68; 2.22) 1.251 (0.68; 20.36)